AstraZeneca, breast cancer and Daiichi Sankyo
AstraZeneca Receives FDA Approval for Enhertu Breast Cancer Treatment
AstraZeneca received Food and Drug Administration approval for enhertu, its breast cancer treatment developed in partnership with Japanese company Daiichi Sankyo. The Anglo-Swedish pharmaceutical company said Monday that the treatment's approval was based on results from a Phase III trial,
The findings suggest that reconsideration of current clinical guidelines, which support MRI only for symptomatic brain ...
A breast cancer diagnosis often arrives as a profound turning point, bringing uncertainty and complex emotions. While the ...
From left, Newfield boys basketball players Bryce Goodman, Mat Evers and Ranard Fields as well as other team members ...
Verywell Health on MSN18h
8 Ways to Combat Isolation With a Metastatic Breast Cancer DiagnosisSeveral studies show that isolation is very common among those diagnosed with metastatic breast cancer. However, there are ...
The process impacts physical movement and emotional well-being, but specific stretching exercises can significantly improve ...
Writer Amy Wallen took on a 60-mile Susan G. Komen challenge as a way to test her stamina while doing something positive for ...
After living with metastatic breast cancer for 11 years, I reflect on my journey and plan to embrace the coming year with ...
A casual stroll down San Francisco's Union Street in early January led 38-year-old Jenna Williams to a life-saving discovery.
Actress Rozlyn Khan has accused Hina Khan of bribing her doctor, Dr Mandar Nadkarni in order to keep the details of her ...
The University of Iowa study is analyzing the period between breast cancer diagnosis and treatment, when many patients feel ...
To direct more attention toward the importance of regular breast cancer screenings, Novartis is taking to one of television’s ...
Carrie's TOUCH presents 'Dinner with the Youngers,' a live reading of Lorraine Hansberry's 'A Raisin in the Sun,' to raise ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback